Dexmedetomidine Alleviates Acute Kidney Injury in a Rat Model of Veno-arterial Extracorporeal Membrane Oxygenation

Overview

Journal Intensive Care Med Exp

Date 2025 Jan 30

PMID 39884997

Authors

Min Yu

Shilin Wei

Xueyang Shen

Junjie Ying

Dezhi Mu

Xiangyang Wu

Yongnan Li

Affiliations

Soon will be listed here.

Abstract

Background: Although extracorporeal membrane oxygenation (ECMO) is an effective technique for life support, the incidence of acute kidney injury (AKI) during ECMO support remains high. Dexmedetomidine (DEX), which has been widely used for sedation during ECMO, possesses several properties that help reduce the occurrence of AKI. This study aimed to investigate the protective effect of DEX on kidney function during ECMO.

Methods: A total of 18 male Sprague-Dawley (SD) rats were randomly divided into three groups: Sham, ECMO, and ECMO + DEX groups. ECMO was established through the right jugular vein for venous drainage and right femoral artery for arterial infusion and lasts for four hours. Hematoxylin and eosin staining was used to evaluate the kidney Paller score for the rats in each group. Enzyme-linked immunosorbent assay was used to measure the levels of kidney injury biomarkers and cytokines in the serum. Reagent kits were used to measure the blood urea nitrogen (BUN) and creatinine (Cr) levels, which helped determine kidney function. Immunohistochemical staining was used to evaluate neutrophil infiltration in the kidney.

Results: The pathological Paller score was substantially lower in the ECMO + DEX group. The levels of Kidney Injury Molecule-1 (KIM-1) and N-acetyl-β-D-glucosaminidase (NAG) were also significantly reduced. The kidney functionality, as indicated by BUN and Cr, was significantly improved compared with the ECMO group. The levels of cytokines IL-6, IL-1β, and TNF-α, were also significantly decreased in the ECMO + DEX group.

Conclusion: This study demonstrated that dexmedetomidine could reduce inflammatory response and alleviate AKI during ECMO support.

References

Ratnani I, Tuazon D, Zainab A, Uddin F . The Role and Impact of Extracorporeal Membrane Oxygenation in Critical Care. Methodist Debakey Cardiovasc J. 2018; 14(2):110-119. PMC: 6027718. DOI: 10.14797/mdcj-14-2-110. View

Marhong J, DeBacker J, Viau-Lapointe J, Munshi L, Del Sorbo L, Burry L . Sedation and Mobilization During Venovenous Extracorporeal Membrane Oxygenation for Acute Respiratory Failure: An International Survey. Crit Care Med. 2017; 45(11):1893-1899. DOI: 10.1097/CCM.0000000000002702. View

Wang K, Wu M, Xu J, Wu C, Zhang B, Wang G . Effects of dexmedetomidine on perioperative stress, inflammation, and immune function: systematic review and meta-analysis. Br J Anaesth. 2019; 123(6):777-794. DOI: 10.1016/j.bja.2019.07.027. View

Hayama T, Matsuyama M, Funao K, Tanaka T, Tsuchida K, Takemoto Y . Benefical effect of neutrophil elastase inhibitor on renal warm ischemia-reperfusion injury in the rat. Transplant Proc. 2006; 38(7):2201-2. DOI: 10.1016/j.transproceed.2006.06.094. View

Paller M, Hoidal J, FERRIS T . Oxygen free radicals in ischemic acute renal failure in the rat. J Clin Invest. 1984; 74(4):1156-64. PMC: 425281. DOI: 10.1172/JCI111524. View

Soliman I, Frencken J, Peelen L, Slooter A, Cremer O, van Delden J . The predictive value of early acute kidney injury for long-term survival and quality of life of critically ill patients. Crit Care. 2016; 20(1):242. PMC: 4973091. DOI: 10.1186/s13054-016-1416-0. View

Fouilloux V, Gran C, Ghez O, Chenu C, El Louali F, Kreitmann B . Mobile extracorporeal membrane oxygenation for children: single-center 10 years' experience. Perfusion. 2019; 34(5):384-391. DOI: 10.1177/0267659118824006. View

Chrysostomou C, Di Filippo S, Manrique A, Schmitt C, Orr R, Casta A . Use of dexmedetomidine in children after cardiac and thoracic surgery. Pediatr Crit Care Med. 2006; 7(2):126-31. DOI: 10.1097/01.PCC.0000200967.76996.07. View

Linkermann A, Brasen J, Darding M, Jin M, Sanz A, Heller J . Two independent pathways of regulated necrosis mediate ischemia-reperfusion injury. Proc Natl Acad Sci U S A. 2013; 110(29):12024-9. PMC: 3718149. DOI: 10.1073/pnas.1305538110. View

10.

Li A, Yuen V, Goulay-Dufay S, Kwok P . Pharmacokinetics and pharmacodynamics of dexmedetomidine. Drug Dev Ind Pharm. 2016; 42(12):1917-1927. DOI: 10.1080/03639045.2016.1232727. View

11.

Kang K, Gao Y, Wang S, Liu H, Kong W, Zhang X . Dexmedetomidine protects against lipopolysaccharide-induced sepsis-associated acute kidney injury via an α7 nAChR-dependent pathway. Biomed Pharmacother. 2018; 106:210-216. DOI: 10.1016/j.biopha.2018.06.059. View

12.

Tao W, Shan X, Zhang J, Liu H, Wang B, Wei X . Dexmedetomidine Attenuates Ferroptosis-Mediated Renal Ischemia/Reperfusion Injury and Inflammation by Inhibiting ACSL4 α2-AR. Front Pharmacol. 2022; 13:782466. PMC: 9307125. DOI: 10.3389/fphar.2022.782466. View

13.

Linkermann A, Skouta R, Himmerkus N, Mulay S, Dewitz C, De Zen F . Synchronized renal tubular cell death involves ferroptosis. Proc Natl Acad Sci U S A. 2014; 111(47):16836-41. PMC: 4250130. DOI: 10.1073/pnas.1415518111. View

14.

Napp L, Ziegeler S, Kindgen-Milles D . Rationale of Hemoadsorption during Extracorporeal Membrane Oxygenation Support. Blood Purif. 2019; 48(3):203-214. PMC: 6878728. DOI: 10.1159/000500015. View

15.

Cheng R, Hachamovitch R, Kittleson M, Patel J, Arabia F, Moriguchi J . Complications of extracorporeal membrane oxygenation for treatment of cardiogenic shock and cardiac arrest: a meta-analysis of 1,866 adult patients. Ann Thorac Surg. 2013; 97(2):610-6. DOI: 10.1016/j.athoracsur.2013.09.008. View

16.

Zangrillo A, Landoni G, Biondi-Zoccai G, Greco M, Greco T, Frati G . A meta-analysis of complications and mortality of extracorporeal membrane oxygenation. Crit Care Resusc. 2013; 15(3):172-8. View

17.

Millar J, Fanning J, McDonald C, McAuley D, Fraser J . The inflammatory response to extracorporeal membrane oxygenation (ECMO): a review of the pathophysiology. Crit Care. 2016; 20(1):387. PMC: 5125043. DOI: 10.1186/s13054-016-1570-4. View

18.

Wei S, Cheng X, Li J, Zhai K, Huang J, Wang S . Venoarterial extracorporeal membrane oxygenation improves survival in a rat model of acute myocardial infarction. Artif Organs. 2023; 47(7):1163-1173. DOI: 10.1111/aor.14499. View

19.

Gertler R, Brown H, Mitchell D, Silvius E . Dexmedetomidine: a novel sedative-analgesic agent. Proc (Bayl Univ Med Cent). 2005; 14(1):13-21. PMC: 1291306. DOI: 10.1080/08998280.2001.11927725. View

20.

Okamoto M, Kawaguchi D, Amin A . Evaluation of propofol infusion syndrome in pediatric intensive care. Am J Health Syst Pharm. 2003; 60(19):2007-14. DOI: 10.1093/ajhp/60.19.2007. View